With $45M Nurix Deal, Gilead Enters Crowded Protein Degradation Field

Reviving tired T cells to improve immuno-oncology treatments

InFarm Joins Vertical Farming Pantheon With Titanic $100m Series B

Global CAR T Cell Therapy Market Innovation By Leading Players

A Study of More Than 250 Platforms Reveals Why Most Fail

UK Immune Cell Therapy Biotech Founded with €40M Series A

What's driving the Gene Therapy Market trends?

Vertex pays Kymera $70M upfront to discover protein degradation drugs

Tumor Cell Dormancy—Triggered by the Niche

Servier launches U.S. cancer business with plans to double headcount in next 5 years

Personalized medicine: Time for one-person trials

Ninjacart Raises $89m from Tiger Global in India’s Largest-Ever Farm Tech Deal

The Changing Relationship Between Academia and Entrepreneurship

AbbVie hands Voyager a mega-billions gene therapy deal, with $310M in near-term cash

Gene-editing technology to create virus-resistant cassava plant has opposite effect

AbbVie puts up $105M for Tizona's preclinical I/O drug

The top 20 preclinical biotech deals ranked by cash upfront reveals 3 big players — and some major l

Our tip of the month: "The patent applicaiton can be Provisional but the invention must be mature"

A 1.2 Bilion Gene Therapy Deal

Big Data Takes on Cancer